Am I missing something?, page-25

Watched the presentation. I thoroughly enjoyed it. It makes clear what the company is doing and where it is heading. There is a growing demand for drug for Alzheimer today. With the increase in life expectancy, there will be more people living with Alzheimer in future and demand for the drug is going to increase even more.

CEO looks confident on what he is doing. I agree with him completely that if the current studies show some statistically significant improvement, raising fund will not be an issue.

Few years ago, when Bill Gates father died of Alzheimer, he promised to invest 100 million of his personal money in the research of Alzheimer disease research.
Raising money is not a big issue , developing an effective drug is the hardest part. The current study looks promising and is on the right direction.
People became impatient today when they heard that the result will be published on 22 and 23. We live in a fast paced world where we want everything now.

I was a big holder of IMU but became impatient and sold few months ago, just before the drug was used in Mayo Clinic. When i look on the SP today, i feel stupid for not being patient enough. Developing any drug needs years of researches and patience is very important.